Ksp Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 36.02%
(FY 2022)
- Profit 26.99%
(FY 2022)
- Ebitda 37.53%
(FY 2022)
- Net Worth 57.82%
(FY 2022)
- Total Assets 21.61%
(FY 2022)
About Ksp Life Science
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kommuri Babu and Sunanda Kommuri serve as directors at the Company.
- CIN/LLPIN
U24304TG2020PTC139771
- Company No.
139771
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Ksp Life Science Private Limited offer?
Ksp Life Science Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Inflammatory and Immunosuppressant API, Cardiovascular Drugs & Medication, Diabetes Medicine.
Who are the key members and board of directors at Ksp Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kommuri Babu  | Director | 13-Mar-2020 | Current |
| Sunanda Kommuri | Director | 13-Mar-2020 | Current |
Financial Performance of Ksp Life Science.
Ksp Life Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.02% increase. The company also saw a substantial improvement in profitability, with a 26.99% increase in profit. The company's net worth Soared by an impressive increase of 57.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ksp Life Science?
Unlock access to Ksp Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ksp Life Science?
Unlock and access historical data on people associated with Ksp Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ksp Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ksp Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
